CCS
ZGNX

Crosspoint Capital Strategies’s Zogenix, Inc. ZGNX Stock Holding History

Crosspoint Capital Strategies’s Portfolio ZGNX Stock Details ZGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-293
Closed -$11K – 684
2013
Q4 		$11K Buy
+293
New +$6.57K ﹤0.01% 425

Other funds holding ZGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Crosspoint Capital Strategies's ZGNX Position: Q1 2014 in Review

Crosspoint Capital Strategies sold out of Zogenix, Inc. (ZGNX) in Q1 2014, closing a stake of 293 shares — an estimated $11K sold.

Crosspoint Capital Strategies first reported a position in ZGNX in Q4 2013 and held it in 1 quarter. The position peaked at $11K in Q4 2013. 83 funds tracked by Wall St. Rank hold ZGNX as of Q1 2014.

  • Crosspoint Capital Strategies reported no remaining Zogenix, Inc. position as of Q1 2014 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 293 Zogenix, Inc. shares in Q1 2014, an estimated $11K.
  • Crosspoint Capital Strategies first reported a position in Zogenix, Inc. in Q4 2013 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Zogenix, Inc. position peaked at $11K in Q4 2013.
  • 83 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2014.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2014, filed 23 Apr 2014.